Zhejiang Meibaolong Biotechnology Co., Ltd., established on 2011-11-28, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Agricultural Science Research and Experimental Development;Engineering and Technology Research and Experimental Development;R&D and application of cell technology;Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Specialty Chemicals Sales(Free of Hazardous Chemicals);Research and development of bio-based materials technology;Manufacturing of bio-based materials;Sales of bio-based materials;Sales of plastic products;Chemical product sales(No licensed chemical products);Instrument sales;Experimental analysis instrument sales;Drug testing equipment sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Veterinary drug production;Veterinary drug business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

L'Air Liquide SA engages in gas supply for large industry and health businesses. It operates through the following segments: Gas & Services, Engineering & Construction, and Global Markets & Technologies. The Gas & Services segment activities are organized by geographical areas, which determine sales policies and development projects. The Engineering & Construction segment designs, develops and builds industrial gas production plants. The Global Markets & Technologies segment focuses on new markets which require a global approach, drawing on science, technologies, development models, and usages related to digital transformation. The company was founded by Georges Claude and Paul Delorme on November 8, 1902 and is headquartered in Paris, France.

AVM is a clinical-stage biotech company located in Seattle WA led by Dr. Theresa Deisher, a biotech veteran with a productive history including 47 patents and 4 discoveries in clinical trials. The company's lead drug AVM0703, an innovative formulation of dexamethasone, when given at suprapharmacologic doses has a novel mechanism of action to mobilize the body's own natural supercharged immune cells. AVM0703 could be the first choice for no-option cancer, autoimmunity, and infectious disease. AVM Biotechnology has a Scientific Advisory Board including well-respected leaders in cancer and immunology.

Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept Injection for subcutaneous use; ZALTRAP for metastatic colorectal cancer; trap fusion proteins; and fully human monoclonal antibodies. On March 26, 2012, it was announced that Sanofi and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72%. Regeneron Pharmaceuticals was founded in 1988 and is currently headquartered in New York, USA.

Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.

Yeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science. Yeda holds an exclusive agreement with the Weizmann Institute to commercialize the unique intellectual property developed by the scientists. The income generated serves to support further basic research and science education. - Identify and assess research projects with commercial potential. - Protect the intellectual property of the Institute and its scientists. - Create business relationships and license the Institute’s inventions and technologies to the industry. - Channel funding from industry to research projects. For further information please contact Tamir Huberman, CIO and Head of Marketing

UCB Pharma SA manufactures pharmaceutical products. It develops products in areas, such as epilepsy, central nervous system, immunology and inflammation. The company is headquartered in Molins de Rei, Spain

Inbiose is a B2B biotech company that develops specialty carbohydrates. Inbiose's proprietary, sustainable, and environmentally friendly platform enables the industrial production of specialty glycans that benefit both human and animal health. They provide products that include carbohydrates, infant food formulas, nutraceuticals, human milk oligosaccharides, and glycans.

Bayer HealthCare Ltd., established on 1995-08-25, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Drug import and export;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;food sales;Health food production;food production;Production of formula food for special medical purpose;Cosmetic production;Production of hygiene products and single-use medical products;Disinfectant production(Free of Hazardous Chemicals).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Cosmetics Wholesale;Cosmetics Retail;internet sales(Except for products that require a license for sale);Food import and export;software development;software sales;Retailing of computer software, hardware and auxiliary equipment;Wholesale of computer software, hardware and auxiliary equipment;Manufacturing of computer software, hardware and peripheral equipment;Software outsourcing service;Information Consulting Service(Not including licensing information consulting services);Information Technology Consulting Services;Special Equipment Repair;Import and export;Technology Import and Export;Import and export agency;Sales of hygiene products and single-use medical products;Disinfectant sales(Free of Hazardous Chemicals);Manufacturing of daily chemical products;Sales of daily chemical products.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Linde provides dry ice, gas equipment, and welding equipment. They provide products for metal fabrication, virtual shopping, healthcare, laboratories, electronics, and e-business. They also provide welding, cutting, automation, gas supply modes, and productivity enhancements.

Part of Lonza Group AG, Lonza Ltd. is a company headquartered in Basel, Switzerland, that supplies chemicals for pharmacy industry.

Biofluid Technologies is committed to offering the highest quality Fetal Bovine Serum available.

Celltech R&D Ltd., a subsidiary of UCB SA, is a British company located in Slough that engages in drug discovery and development. It was founded in 1980.

Particle Measuring Systems Srl produces scientific monitoring devices. It specializes in particle counting and monitoring instrumentation, molecular gas analyzers, data management and automation software, and calibration and maintenance. The company was founded in 1972 and is headquartered in Frascati, Italy.

Takara Bio Inc., develops, manufactures, and distributes a wide range of life science reagents and kits under the Takara®, Clontech®, and Cellartis® brands. Key products include SMART® cDNA synthesis kits for a variety of samples and applications, including NGS; high-performance qPCR and PCR reagents (including the Takara Ex Taq®, Takara LA Taq®, Titanium®, and Advantage® enzymes); Cellartis stem cells and stem cell reagents; RT enzymes and SMART library construction kits; the innovative In-Fusion® cloning system; Guide-it™ gene editing tools; Tet-based inducible gene expression systems; and Living Colors® fluorescent proteins. These and other products support applications including NGS; gene discovery, regulation, and function studies; protein expression and purification; RNAi, gene editing, and stem cell studies; and plant and food research

Baxter Healthcare SA engages in the development, production, and sale of healthcare systems and products. It also acquires and manages participations in pharmaceutical-chemical firms. The company was founded on December 7, 2000 and is headquartered in Glattpark, Switzerland.

Pulike Biological Engineering, Inc. engages in the research, development, manufacturing and sale of biological products for animals, chemical drugs and Chinese veterinary drugs. Its products include genetic engineering vaccines and multivalent vaccines. The company also provides technical services. Pulike Biological Engineering was founded in 1995 and is headquartered in Luoyang, China.

Baxter AG, part of Baxter International, Inc., is a company headquartered in Volketswell, Switzerland. The firm wholesales pharmaceutical products.

Yunnan Moore Farm Biotechnology Development Co., Ltd., established on 2006-06-23, Business scope includes import and export trade;Grain purchase and sale;food,Health food production,operate;nut,Fruit growing and selling;Planting and processing of Chinese herbal medicines;Biotechnology product development;Agricultural and sideline native products,Minerals,electronic product,Sales of building materials;laboratory testing;Product certification technical consultation;Manufacture of special equipment for agricultural and sideline food processing;other farmers,Forest,animal husbandry,Fishing machinery manufacturing;Agricultural Machinery Wholesale;Production of Class II Medical Devices;Wholesale and retail of Class II medical devices;Manufacture of other industrial textile products;textile,Wholesale of knitted goods and raw materials;Retailing of Textiles and Knitwear.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)